Is ACADIA Pharmaceuticals Inc. overvalued?

ACADIA Pharmaceuticals Inc. (ACAD) looks overvalued — trading about 17% above its fair value.

Overvalued

Price

$28.38

Fair value

$23.49

Current P/E

13.9

Normal P/E

11.5

Market cap

$4.86B

Dividend yield

0.0%

Return on equity

32.4%

Sector

Healthcare

Fair value compares ACAD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks